Bortezomib and gemcitabine in relapsed or refractory Hodgkin's lymphoma.
Mendler JH; Kelly J; Voci S; Marquis D; Rich L; Rossi RM; Bernstein SH; Jordan CT; Liesveld J; Fisher RI; Friedberg JW; Annals Of Oncology: Official Journal Of The European Society For Medical Oncology / ESMO, 2008, vol. 19, issue 10, p 1759, ISSN 15698041. ISBN 15698041.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef